Business · Companies · 17 hrs ago
Three South Korean drugmakers seek partners at Bio-Europe in Cologne
Alteogen, LigaChem Biosciences and Jeil Pharmaceutical are attending Bio-Europe in Cologne, Germany, from Nov.
9 to 11.
The event is a partnering meeting for biotechnology and pharmaceutical companies.
Alteogen and its subsidiary plan to discuss development opportunities for a candidate to treat age-related macular degeneration and seek partners for a drug-delivery platform.
Jeil Pharmaceutical will present two drug candidates and a diabetes combination treatment to potential partners.
The companies are looking for licensing deals and overseas business cooperation.
LigaChem also plans to attend a healthcare conference in London from Nov.
16 to 19, while no specific outcome from the Cologne meetings has been announced.
Alteogen, LigaChem Biosciences and Jeil Pharmaceutical will attend the Bio-Europe partnering event in Cologne, Germany, from November 9 to 11.
Alteogen plans to discuss business development for its age-related macular degeneration drug candidate and seek partners for its Hybrozyme platform.
Jeil Pharmaceutical will present three assets, including candidates for diabetes and cancer, and seek licensing and overseas business opportunities.
LigaChem Biosciences will use the event to expand its pipeline and advance clinical development of key assets.
- Who
- Alteogen, LigaChem Biosciences and Jeil Pharmaceutical, three South Korean drugmakers.
- What
- They will attend Bio-Europe to discuss drug and technology assets and seek potential partners.
- When
- November 9–11, 2026.
- Where
- Cologne, Germany.
- Why
- To explore business development, partnership, licensing and overseas cooperation opportunities.
This story does not have two clearly opposing sides.
The companies announced their plans to participate in Bio-Europe.
Bio-Europe is scheduled to take place in Cologne, Germany.
LigaChem Biosciences is also scheduled to attend the Jefferies Global Healthcare Conference in London.
- Event
- Bio-Europe
- Location
- Cologne, Germany
- Event dates
- November 9–11, 2026
- Alteogen asset
- ALTS-OP01, an age-related macular degeneration drug candidate
- Jeil Pharmaceutical assets
- JP-2266, JP9441 and Duglow
- LigaChem follow-up event
- Jefferies Global Healthcare Conference, London, November 16–19, 2026